Most cited papers in Clusterin in disease pathology

Clusterin in disease pathology

What are the most cited papers in Clusterin in disease pathology?

The most cited paper in Clusterin in disease pathology is "Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease" (Paulina V. Arriagada, John H. Growdon, E. Tessa Hedley‐Whyte et al., 1992), with 2,723 citations. Next come "What are biomarkers?" (2,054) and "Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer" (1,774).

Published TypeAccessAuthorsCitations

Showing 50 of 100 papers. Every paper with more than 288 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease Paulina V. Arriagada, John H. Growdon, E. Tessa Hedley‐Whyte et al. · Neurology	Mar 1992	2,723
2	What are biomarkers? Kyle Strimbu, Jorge A. Tavel · Current Opinion in HIV and AIDS Open access	21 Aug 2010	2,054
3	Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer Balázs Győrffy · Computational and Structural Biotechnology Journal Open access	2021	1,774
4	Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers Susanne Schöttler, Greta Becker, Svenja Winzen et al. · Nature Nanotechnology	12 Feb 2016	1,267
5	Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. D G Bostwick, D J Grignon, M. Elizabeth H. Hammond et al. · PubMed	Jul 2000	1,246
6	Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Alexis Desmoulière, Mireille Redard, Ian Andrew Darby et al. · PubMed Open access	1995	1,190
7	Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group Glenn J. Bubley et al. · Journal of Clinical Oncology	Nov 1999	987
8	Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer Mingzhao Xing et al. · JAMA Open access	9 Apr 2013	943
9	Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes Michael S. Cookson, Gunnar Aus, Arthur L. “Bud” Burnett et al. · The Journal of Urology	11 Jan 2007	848
10	FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations Nan Zhou, Jinku Bao · Database Open access	2020	846
11	Gene Expression Alterations in Prostate Cancer Predicting Tumor Aggression and Preceding Development of Malignancy Yan Yu, Douglas P. Landsittel, Ling Jing et al. · Journal of Clinical Oncology	14 Jul 2004	789
12	A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome) Hiroshi Inoue, Yukio Tanizawa, Jon Wasson et al. · Nature Genetics	Oct 1998	764
13	The two faces of transforming growth factor β in carcinogenesis Anita B. Roberts, Lalage M. Wakefield · Proceedings of the National Academy of Sciences Open access	14 Jul 2003	749
14	Association of TNF2, a TNF-α Promoter Polymorphism, With Septic Shock Susceptibility and Mortality Jean‐Paul Mira, Alain Cariou, Franck T. Grall et al. · JAMA	11 Aug 1999	742
15	High-Throughput Mapping of a Dynamic Signaling Network in Mammalian Cells Miriam Barrios‐Rodiles, Kevin R. Brown, Barish Ozdamar et al. · Science	10 Mar 2005	731
16	Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis Pengfei Liu, Yetong Feng, Hanwei Li et al. · Cellular & Molecular Biology Letters Open access	27 Feb 2020	715
17	Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47 John D. MacMicking, Gregory Alan Taylor, John D. McKinney · Science Open access	23 Oct 2003	698
18	Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer Eric Mark Horwitz, Kyounghwa Bae, Gerald E. Hanks et al. · Journal of Clinical Oncology Open access	15 Apr 2008	696
19	A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling Eric A. Klein, Matthew R. Cooperberg, Cristina Magi‐Galluzzi et al. · European Urology Open access	16 May 2014	680
20	Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy Scott E. Eggener, Peter T. Scardino, Patrick C. Walsh et al. · The Journal of Urology Open access	16 Jan 2011	646
21	Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 Silke Gillessen et al. · European Urology Open access	24 Jun 2017	644
22	Iron‐dependent cell death of hepatocellular carcinoma cells exposed to sorafenib Christophe Louandre, Zakaria Ezzoukhry, Corinne Godin et al. · International Journal of Cancer	18 Mar 2013	614
23	Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. Ralph Witzgall, Dennis J. Brown, Christoph C. Schwarz et al. · Journal of Clinical Investigation Open access	May 1994	612
24	Proteomic patterns of tumour subsets in non-small-cell lung cancer Kiyoshi Yanagisawa, Yu Shyr, Baogang J. Xu et al. · The Lancet	Aug 2003	601
25	Prostate-Specific Antigen–Based Screening for Prostate Cancer Joshua J. Fenton, Meghan S. Weyrich, Shauna Durbin et al. · JAMA Open access	8 May 2018	566
26	LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling Xiaomeng Wang, Sabu Abraham, Jenny A. G. McKenzie et al. · Nature Open access	16 Jul 2013	564
27	TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas Miguel Manuel Melo et al. · The Journal of Clinical Endocrinology & Metabolism Open access	29 Jan 2014	558
28	The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline Rebecca J. Brown, David Araújo‐Vilar, Pik To Cheung et al. · The Journal of Clinical Endocrinology & Metabolism Open access	6 Oct 2016	539
29	Prostate‐specific antigen: A review of the validation of the most commonly used cancer biomarker Javier Hernández, Ian Murchie Thompson · Cancer	2 Jul 2004	530
30	Neuronal Death After Hemorrhagic Stroke In Vitro and In Vivo Shares Features of Ferroptosis and Necroptosis Marietta Zille, Saravanan S. Karuppagounder, Yingxin Chen et al. · Stroke Open access	2 Mar 2017	529
31	Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer Mingzhao Xing et al. · Journal of Clinical Oncology Open access	21 Oct 2014	527
32	Molecular mechanisms of tumor resistance to radiotherapy Yu Wu, Yingqiu Song, Runze Wang et al. · Molecular Cancer Open access	15 Jun 2023	517
33	Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness Jean S. Kutner et al. · JAMA Internal Medicine Open access	23 Mar 2015	505
34	Defective forebrain development in mice lacking gp330/megalin. Thomas E. Willnow, Jan H. Hilpert, Scott A. Armstrong et al. · Proceedings of the National Academy of Sciences Open access	6 Aug 1996	491
35	Clusterin S Jones · The International Journal of Biochemistry & Cell Biology	May 2002	490
36	Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data Baolin Wu, Tom E.F. Abbott, David A. Fishman et al. · Bioinformatics Open access	Sep 2003	485
37	Prevalence of statin intolerance: a meta-analysis Ibadete Bytyçi, Peter Edward Penson, Dimitri P. Mikhailidis et al. · European Heart Journal ReviewOpen access	11 Jan 2022	476
38	Induction of the TRPM-2 gene in cells undergoing programmed death. Ralph O'Toole Buttyan, Craig A. Olsson, John E. Pintar et al. · Molecular and Cellular Biology Open access	Aug 1989	463
39	Clusterin Has Chaperone-like Activity Similar to That of Small Heat Shock Proteins David T. Humphreys, John A. Carver, Simon B. Easterbrook‐Smith et al. · Journal of Biological Chemistry Open access	Mar 1999	459
40	Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis Siddharth Singh, Preet Paul Singh, Abha Goyal Singh et al. · Gastroenterology Review	11 Oct 2012	458
41	The Involution of the Ageing Human Thymic Epithelium is Independent of Puberty Gerhard G. Steinmann, BEATE M. KLAUS, Hans Konrad Müller-Hermelink · Scandinavian Journal of Immunology	Nov 1985	458
42	Clusterin inhibits apoptosis by interacting with activated Bax Honglai Zhang, Jin Koo Kim, Chris A. Edwards et al. · Nature Cell Biology	21 Aug 2005	458
43	A review of the S100 proteins in cancer Iman I. Salama, Peter Malone, Faisal Mihaimeed et al. · European Journal of Surgical Oncology	14 Jun 2007	457
44	ApoE and Clusterin Cooperatively Suppress Aβ Levels and Deposition Ronald Bradley Demattos, John R. Cirrito, Maia Parsadanian et al. · Neuron Open access	2004	453
45	TERT promoter mutations in thyroid cancer Rengyun Liu, Mingzhao Xing · Endocrine Related Cancer Open access	5 Jan 2016	446
46	Contemporary Trends in Low Risk Prostate Cancer: Risk Assessment and Treatment Matthew R. Cooperberg, Jeanette M. Broering, Philip W. Kantoff et al. · The Journal of Urology Open access	21 Jul 2007	444
47	Exercise plasma boosts memory and dampens brain inflammation via clusterin Zurine D. Miguel et al. · Nature Open access	8 Dec 2021	440
48	Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019) Nicholas David James, Melissa Ruth Spears, Noel William Clarke et al. · European Urology Open access	7 Oct 2014	440
49	Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers. Berislav V. Zloković, C.L. Martel, E. Matsubara et al. · Proceedings of the National Academy of Sciences Open access	30 Apr 1996	435
50	Clusterin: Physiologic and pathophysiologic considerations Mark E. Rosenberg, John R. Silkensen · The International Journal of Biochemistry & Cell Biology Open access	Jul 1995	433

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.